Vector Vitale has discovered that isotope selective medicine through the symmetry correction of biomolecules may change our future by reversing the effect of common pathogens in our body.

Our proprietary technology allows for improvement of numerous existing pharmaceutical preparations, and creation of new products to satisfy unmet needs not only for seriously ill patients, but also for virtually anybody who wants to stay young and healthy.


Vector Vitale, Inc. is an interdisciplinary research-based company focused on development and commercialization of a new type of medicine: isotope selective diagnostics, therapy and prevention of diseases, and aging.

© Copyright 2015 - Vector Vitale